Genprex Stock Buy Hold or Sell Recommendation
| GNPX Stock | USD 2.21 0.10 4.33% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Genprex is 'Strong Hold'. Macroaxis provides Genprex buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Genprex positions. The advice algorithm takes into account all of Genprex's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Genprex's buy or sell advice are summarized below:
Real Value 3.08 | Target Price 5.5 | Hype Value 1.96 | Market Value 2.21 | Naive Value 1.6 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Genprex given historical horizon and risk tolerance towards Genprex. When Macroaxis issues a 'buy' or 'sell' recommendation for Genprex, the advice is generated through an automated system that utilizes algorithms and statistical models.
Genprex |
Execute Genprex Buy or Sell Advice
The Genprex recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Genprex. Macroaxis does not own or have any residual interests in Genprex or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Genprex's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Genprex Trading Alerts and Improvement Suggestions
| Genprex generated a negative expected return over the last 90 days | |
| Genprex has high historical volatility and very poor performance | |
| Genprex has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (30.86 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Genprex currently holds about 25.52 M in cash with (24.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.53. | |
| Genprex has a frail financial position based on the latest SEC disclosures | |
| Latest headline from investing.com: Genprex expands trial sites for lung cancer therapy |
Genprex Returns Distribution Density
The distribution of Genprex's historical returns is an attempt to chart the uncertainty of Genprex's future price movements. The chart of the probability distribution of Genprex daily returns describes the distribution of returns around its average expected value. We use Genprex price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Genprex returns is essential to provide solid investment advice for Genprex.
| Mean Return | -1.63 | Value At Risk | -17.26 | Potential Upside | 9.96 | Standard Deviation | 7.54 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Genprex historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Genprex Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Genprex is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genprex backward and forwards among themselves. Genprex's institutional investor refers to the entity that pools money to purchase Genprex's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Silvercrest Asset Management Group Llc | 2023-12-31 | 56 K | Staley Capital Advisers Inc | 2023-12-31 | 50 K | Ubs Group Ag | 2023-12-31 | 43.1 K | Stonex Group Inc | 2023-12-31 | 35.1 K | Tcg Advisory Services, Llc | 2023-12-31 | 33.5 K | Group One Trading, Lp | 2023-12-31 | 33.1 K | Verus Capital Partners, Llc | 2023-12-31 | 31 K | Visionary Horizons Llc | 2023-12-31 | 30 K | Millennium Management Llc | 2023-12-31 | 28.2 K | Vanguard Group Inc | 2023-12-31 | 1.8 M | Cvi Holdings Llc | 2023-12-31 | 618.3 K |
Genprex Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (6.6M) | 25.3M | 11.3M | (17.7M) | (14.2M) | (13.5M) | |
| Free Cash Flow | (7.9M) | (16.3M) | (14.4M) | (17.8M) | (24.8M) | (23.6M) | |
| Depreciation | 13.1K | 22.8K | 22.5K | 25.6K | 15.0K | 13.6K | |
| Capital Expenditures | 946.9K | 2.3M | 83.8K | 59.7K | 71.4K | 67.8K | |
| Net Income | (10.7M) | (17.9M) | (19.6M) | (23.7M) | (30.9M) | (29.3M) | |
| End Period Cash Flow | 2.0M | 27.3M | 38.6M | 21.0M | 6.7M | 13.0M | |
| Change To Netincome | 3.5M | 4.2M | 4.3M | 4.7M | 5.4M | 3.7M | |
| Investments | (946.9K) | (2.3M) | (83.8K) | 97.7K | 76.1K | 79.9K | |
| Other Non Cash Items | 3.4M | 4.5M | 4.6M | (1.0) | 989.5K | 996.4K |
Genprex Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Genprex or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Genprex's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Genprex stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -1.77 | |
β | Beta against NYSE Composite | 1.48 | |
σ | Overall volatility | 7.62 | |
Ir | Information ratio | -0.23 |
Genprex Volatility Alert
Genprex is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Genprex's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Genprex's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Genprex Fundamentals Vs Peers
Comparing Genprex's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Genprex's direct or indirect competition across all of the common fundamentals between Genprex and the related equities. This way, we can detect undervalued stocks with similar characteristics as Genprex or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Genprex's fundamental indicators could also be used in its relative valuation, which is a method of valuing Genprex by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Genprex to competition |
| Fundamentals | Genprex | Peer Average |
| Return On Equity | -2.08 | -0.31 |
| Return On Asset | -1.09 | -0.14 |
| Current Valuation | (2.61 M) | 16.62 B |
| Shares Outstanding | 1.91 M | 571.82 M |
| Shares Owned By Insiders | 0.85 % | 10.09 % |
| Shares Owned By Institutions | 6.55 % | 39.21 % |
| Number Of Shares Shorted | 69.95 K | 4.71 M |
| Price To Earning | (1.09) X | 28.72 X |
| Price To Book | 0.69 X | 9.51 X |
| EBITDA | (31.06 M) | 3.9 B |
| Net Income | (30.86 M) | 570.98 M |
| Cash And Equivalents | 25.52 M | 2.7 B |
| Cash Per Share | 0.53 X | 5.01 X |
| Debt To Equity | 1.11 % | 48.70 % |
| Current Ratio | 10.71 X | 2.16 X |
| Book Value Per Share | 4.99 X | 1.93 K |
| Cash Flow From Operations | (24.74 M) | 971.22 M |
| Short Ratio | 0.80 X | 4.00 X |
| Earnings Per Share | (22.56) X | 3.12 X |
| Target Price | 165.0 | |
| Number Of Employees | 26 | 18.84 K |
| Beta | -0.63 | -0.15 |
| Market Capitalization | 4.41 M | 19.03 B |
| Total Asset | 10.67 M | 29.47 B |
| Retained Earnings | (133.69 M) | 9.33 B |
| Working Capital | 4.28 M | 1.48 B |
| Current Asset | 964.42 K | 9.34 B |
| Current Liabilities | 587.7 K | 7.9 B |
| Net Asset | 10.67 M |
Note: Payment of 2642 shares by John Varner of Genprex subject to Rule 16b-3 [view details]
Genprex Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Genprex . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Genprex Buy or Sell Advice
When is the right time to buy or sell Genprex? Buying financial instruments such as Genprex Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 612.1K | 2.4M | 1.9M | 1.9M | Total Assets | 42.9M | 25.1M | 10.7M | 15.4M |
Use Investing Ideas to Build Portfolios
In addition to having Genprex in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Housewares Thematic Idea Now
Housewares
Companies making housewares accessories and providing houseware services. The Housewares theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Housewares Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Genprex Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Genprex Stock analysis
When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Genprex's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genprex. If investors know Genprex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genprex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (22.56) | Return On Assets (1.09) | Return On Equity (2.08) |
The market value of Genprex is measured differently than its book value, which is the value of Genprex that is recorded on the company's balance sheet. Investors also form their own opinion of Genprex's value that differs from its market value or its book value, called intrinsic value, which is Genprex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genprex's market value can be influenced by many factors that don't directly affect Genprex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genprex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genprex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genprex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.